-

Rambam Doctors Reconstruct IDF Officer’s Shattered Jaw
October 18, 2021 – Thanks to advanced, innovative treatment, doctors at Rambam Health Care Campus were able to reconstruct the shattered jaw of an IDF officer who was seriously wounded during a firefight. Last month, Captain “D”, a company commander from the elite Duvdevan unit, was injured during an encounter with terrorists near Jereconstnin, suffering multiple gunshot wounds to the lower abdomen, and one bullet hit D’s left lower jaw, resulting in multiple facial fractures.…
-

Using New Technology, Rambam Doctors Transplant Two Corneas into Four Different Donors
October 14, 2021 – Cornea replacement may be necessary in cases where this delicate tissue has been damaged. However, patients often find themselves in a prolonged queue for a cornea donation. Using new, state-of-the-art equipment developed by Moria Ophthalmic Instruments, doctors in the Department of Ophthalmology at Rambam Health Care Campus recently split a donor’s donation of two corneas, enabling them to save the vision of four people. Until a few years ago, cornea replacements…
-

Rambam Plays Crucial Role in International Cross-kidney Transplant Operation Involving Israel and the Czech Republic
October 7, 2021 – According to Israel’s National Transplant Center, when altruistic donors register directly and join the organ exchange database, a chain of matches is created, enabling the donor to essentially save many lives. In a complicated and meticulously timed campaign that included exchanging coolers containing kidneys at the airport in the Czech Republic, as well as a 21-hour marathon of surgeries at Rambam Health Care Campus, two residents of Northern Israel have been given…
-

Rambam Study Shows Cancer Patients with Solid Tumors Respond to COVID Vaccinations Like the General Population
October 5, 2021 – Studies conducted in Rambam’s Joseph Fishman Oncology Center are proving the efficacy and safety of COVID-19 vaccinations for cancer patients with solid tumors, and vaccinations—indicating a favorable profile. Following a study conducted last year in Joseph Fishman Oncology Center at Rambam Health Care Campus regarding the outcomes of COVID-19 in cancer patients, a team of researchers in the facility, led by Professor Irit Ben-Aharon, Director of the Division of Oncology, followed the vaccine outcomes…
-

Rambam Expert Raises Epilepsy Awareness via Training Sessions for Educators
September 30, 2021 – Several training sessions were designed for the Israeli educational system to reduce the stigmas associated with epilepsy. The sessions provided tools for educators to use when assisting students suffering from the disorder. Educational staff have dedicated countless hours preparing for the school year, which began in early September. This year, the second to begin against the backdrop of the COVID-19 pandemic, the educational teams prepared by utilizing a hybrid approach that…
-

Rambam Physician Heads International Hematology Conference
September 26, 2021 – For the first time ever, an international conference dealing with immune system and blood clotting issues was hosted by Israel. The conference was organized and led by Dr. Lilach Bonstein, Director of the Blood Bank Laboratory at Rambam Health Care Campus. Dr. Lilach Bonstein, Director of the Blood Bank Laboratory at Rambam Health Care Campus who also serves as Director of the Platelet and Neutrophil Immunology Laboratory, is the first Israeli…
-

The Word “Lockdown” Needs to Disappear from Our Lexicon
September 12, 2021 – Professor Rafi Beyar, the former General Director of Rambam Health Care Campus, remains deeply committed to quality healthcare. Drawing from his own experience and expertise over the years, he has written an informative and thought-provoking editorial for the daily Israeli business news website “Globes”. A new virus has entered our world and become a reality in our lives. At first, we were afraid—we did not know the enemy—and we were all…
-

The Battle against the Coronavirus is a War in Every Sense – We Need to Focus on Both the Frontlines and the Home Front
September 12, 2021 – Dr. Michael Halberthal, Director General of Rambam Health Care Campus, has been tirelessly leading the hospital through the daily challenges of the coronavirus. Below is an editorial he wrote for the Israeli daily newspaper and news website, “Israel Today”. At the beginning of March 2020, the first patient to be diagnosed with COVID-19 entered the gates of our hospital. Today, more than a year-and-a-half later, we are far from the end…
-

Human Interest Story: Rambam Radiographer Saves Life of Drowning Man
August 29, 2021 – A radiographer employed at Rambam Health Care Campus helped perform CPR on a man who suffered a seizure and almost drowned, saving his life. Walaa Sabbagh, a radiographer at Rambam Health Care Campus for the past four years, was spending the day with her family at Gan HaShlosha (Sahne) National Park, when she suddenly heard screams coming from several meters away. Without thinking, Sabbagh jumped up and ran towards the screaming.…
-

Preparations for the New School Year at Ruth Rappaport Children’s Hospital
The 2021–2022 school year will open as scheduled for hospitalized children at the Ruth Rappaport Children’s Hospital of Rambam Health Care Campus. The hospital’s school is run by the BRACHA Education Center under the direction of Israel’s Ministry of Education August 26, 2021 – At Rambam, ten classes are held for hospitalized children ages 3 to 21, including those children who will enter first grade while in hospital. The educations staff invest several days of careful organization and preparation in…
-

Possible COVID Breakthrough: Israeli Ministry of Health Approves Extension of Israeli Drug Trial at Rambam Medical Center to Other Israel Hospitals
August 11, 2021 – The Israeli Ministry of Health confirmed that hospitals will begin treating critically ill COVID-19 patients with a new Israeli drug called “MesenCure“ manufactured by Bonus BioGroup. The decision was made after recent clinical trials with the experimental drug at Rambam, with good results: 14 out of 16 seriously ill COVID-19 patients treated with the drug were discharged from the hospital. Click the link below to learn more- https://www.jpost.com/health-science/israel-to-expand-use-of-covid-drug-that-gets-88-percent-of-patients-out-of-hospital-676397 Treatment with MesenCure…

